Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer

被引:8
|
作者
Qiu, Yang [1 ]
Liu, Yun-Fan [1 ]
Shu, Xin [1 ]
Qiao, Xiao-Feng [1 ]
Ai, Guang-Yong [1 ]
He, Xiao-Jing [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Radiol, Chongqing, Peoples R China
关键词
Gleason grade group; Machine learning; MRI; Peritumoral radiomics; Prostate cancer; ISUP CONSENSUS CONFERENCE; INTERNATIONAL-SOCIETY; TEXTURE ANALYSIS; PERFORMANCE; FEATURES;
D O I
10.1016/j.acra.2023.06.011
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: To develop and evaluate a peritumoral radiomic-based machine learning model to differentiate low-Gleason grade group (L-GGG) and high-GGG (H-GGG) prostate lesions. Materials and Methods: In this retrospective study, a total of 175 patients with prostate cancer (PCa) confirmed by puncture biopsy were recruited and included 59 patients with L-GGG and 116 patients with H-GGG. The original PCa regions of interest (ROIs) were delineated on T2-weighted (T2WI), diffusion-weighted imaging (DWI), and apparent diffusion coefficient (ADC) maps, and then centra-tumoral and peritumoral ROIs were defined. Features were meticulously extracted from each ROI to establish radiomics models, employing distinct sequence datasets. Peritumoral radiomics models were specifically developed for both the peripheral zone (PZ) and transitional zone (TZ), utilizing dedicated PZ and TZ datasets, respectively. The performances of the models were evaluated by using the receiver operating characteristic (ROC) curve and precision-recall curve. Results The classification model with combined peritumoral features based on T2 + DWI + ADC sequence dataset demonstrated superior performance compared to the original tumor and centra-tumoral classification models. It achieved an area under the ROC curve (AUC) of 0.850 [95% confidence interval, 0.849, 0.860] and an average accuracy of 0.950. The combined peritumoral model out-performed the regional peritumoral models with AUC of 0.85 versus 0.75 for PZ lesions and 0.88 versus 0.69 for TZ lesions, respectively. The peritumoral classification models exhibit greater efficacy in predicting PZ lesions as opposed to TZ lesions. Conclusion: The peritumoral radiomics features showed excellent performance in predicting GGG in PCa patients and might be a valuable addition to the non-invasive assessment of PCa aggressiveness.
引用
收藏
页码:S1 / S13
页数:13
相关论文
共 50 条
  • [21] The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer
    Dias, Adriano Basso
    Mirshahvalad, Seyed Ali
    Ortega, Claudia
    Perlis, Nathan
    Berlin, Alejandro
    van der Kwast, Theodorus
    Ghai, Sangeet
    Jhaveri, Kartik
    Metser, Ur
    Haider, Masoom
    Avery, Lisa
    Veit-Haibach, Patrick
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2167 - 2176
  • [22] Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot Study
    Mirshahvalad, Seyed Ali
    Dias, Adriano B.
    Ghai, Sangeet
    Ortega, Claudia
    Perlis, Nathan
    Berlin, Alejandro
    Avery, Lisa
    van der Kwast, Theodorus
    Metser, Ur
    Veit-Haibach, Patrick
    ACADEMIC RADIOLOGY, 2025, 32 (01) : 250 - 259
  • [23] Clinical Outcomes among Patients with Radiorecurrent Gleason Grade Group 5 Prostate Cancer: Impact of Initial Treatment Strategy
    Levin-Epstein, R.
    Cook, K.
    Chu, F. I.
    Ciezki, J. P.
    Stock, R. G.
    Merrick, G. S.
    Demanes, D. J. J.
    Spratt, D. E.
    Abu-Isa, E. I.
    Pomerantz, M.
    Tran, P. T.
    Nguyen, P. L.
    Wedde, T.
    Lilleby, W.
    Krauss, D. J.
    Alam, R.
    Steinberg, M. L.
    Horwitz, E. M.
    King, C. R.
    Kishan, A. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E289 - E290
  • [24] Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
    Marit Lucas
    Ilaria Jansen
    C. Dilara Savci-Heijink
    Sybren L. Meijer
    Onno J. de Boer
    Ton G. van Leeuwen
    Daniel M. de Bruin
    Henk A. Marquering
    Virchows Archiv, 2019, 475 : 77 - 83
  • [25] Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
    Lucas, Marit
    Jansen, Ilaria
    Savci-Heijink, C. Dilara
    Meijer, Sybren L.
    de Boer, Onno J.
    van Leeuwen, Ton G.
    de Bruin, Daniel M.
    Marquering, Henk A.
    VIRCHOWS ARCHIV, 2019, 475 (01) : 77 - 83
  • [26] The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 Prostate Cancer
    Tilki, Derya
    Wuernschimmel, Christoph
    Preisser, Felix
    Graefen, Markus
    Huland, Hartwig
    Mandel, Philipp
    Tennstedt, Pierre
    EUROPEAN UROLOGY FOCUS, 2020, 6 (02): : 255 - 258
  • [27] BIOCHEMICAL, RADIOLOGICAL AND PATHOLOGICAL PREDICTION OF GLEASON DOWNGRADING IN HIGH GRADE PROSTATE CANCER PATIENTS
    Lim, Sey Kiat
    Kim, Kwang Hyun
    Shin, Tae Young
    Rha, Koon Ho
    JOURNAL OF UROLOGY, 2013, 189 (04): : E148 - E148
  • [28] Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer
    Qian, Hongyang
    Shao, Xiaoguang
    Zhu, Yinjie
    Fan, Liancheng
    Zhang, Heng
    Dong, Baijun
    Wang, Yanqing
    Xu, Fan
    Zhen, Wenzhong
    Kang, Xiaonan
    Chen, Na
    Liu, Shupeng
    Pan, Jiahua
    Xue, Wei
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (06) : 601.e1 - 601.e9
  • [29] Prediction of The Gleason Group of Prostate Cancer from Clinical Biomarkers: Machine and Deep Learning from Tabular Data
    Mamdouh, Ahmed
    El-Melegy, Moumen T.
    Ali, Samia A.
    El-Baz, Ayman S.
    2022 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), 2022,
  • [30] Population-based study of Gleason grade group progression in prostate cancer patients with different risk stratifications
    Zhang, L.
    Dai, X.
    Jiang, H.
    Ding, Q.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 32 - 32